Search research articles
Contact Us
Filters
Showing results (41-50 of 96) with videos related to
Page
of 10
Sort By:
The Journal of Clinical Investigation
|
November 1, 1987
Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism
P Gresele, J Arnout, H Deckmyn, et al.
Lancet (London, England)
|
May 5, 1984
BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man
P Gresele, H Deckmyn, J Arnout, et al.
Investigative Radiology
|
November 1, 1985
Intravenous ionic contrast media cause local prostacyclin release in man
P De Maeyer, H Deckmyn, J Arnout, et al.
Thrombosis and Haemostasis
|
December 30, 1983
Dipyridamole inhibits platelet aggregation in whole blood
P Gresele, C Zoja, H Deckmyn, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
December 1, 1990
Non-receptor-mediated refractoriness in prostacyclin production by human endothelial cells in a continuous flow system is delayed by a low-molecular-weight plasma fraction devoid of reducing cofactors for peroxidase-catalysed reactions
J Kienast, J Arnout, H Deckmyn, et al.
Surgical Endoscopy
|
October 1, 1994
Interleukin-6 and coagulation-fibrinolysis fluctuations after laparoscopic and conventional cholecystectomy
G Vander Velpen, F Penninckx, R Kerremans, et al.
The American Journal of Cardiology
|
March 1, 1993
Retreatment with alteplase for early signs of reocclusion after thrombolysis. The European Cooperative Study Group
M L Simoons, J Arnout, M van den Brand, et al.
Thrombosis and Haemostasis
|
August 13, 1990
Ridogrel, a combined thromboxane synthase inhibitor and receptor blocker, decreases elevated plasma beta-thromboglobulin levels in patients with documented peripheral arterial disease
B Hoet, J Arnout, C Van Geet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1988
Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro
M Baba, R Pauwels, J Balzarini, et al.
Thrombosis and Haemostasis
|
February 1, 1993
A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate
K Peerlinck, J Arnout, J G Gilles, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 96) with videos related to
Sort By:
Page
of 10
The Journal of Clinical Investigation
|
November 1, 1987
Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism
P Gresele, J Arnout, H Deckmyn, et al.
Lancet (London, England)
|
May 5, 1984
BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man
P Gresele, H Deckmyn, J Arnout, et al.
Investigative Radiology
|
November 1, 1985
Intravenous ionic contrast media cause local prostacyclin release in man
P De Maeyer, H Deckmyn, J Arnout, et al.
Thrombosis and Haemostasis
|
December 30, 1983
Dipyridamole inhibits platelet aggregation in whole blood
P Gresele, C Zoja, H Deckmyn, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
December 1, 1990
Non-receptor-mediated refractoriness in prostacyclin production by human endothelial cells in a continuous flow system is delayed by a low-molecular-weight plasma fraction devoid of reducing cofactors for peroxidase-catalysed reactions
J Kienast, J Arnout, H Deckmyn, et al.
Surgical Endoscopy
|
October 1, 1994
Interleukin-6 and coagulation-fibrinolysis fluctuations after laparoscopic and conventional cholecystectomy
G Vander Velpen, F Penninckx, R Kerremans, et al.
The American Journal of Cardiology
|
March 1, 1993
Retreatment with alteplase for early signs of reocclusion after thrombolysis. The European Cooperative Study Group
M L Simoons, J Arnout, M van den Brand, et al.
Thrombosis and Haemostasis
|
August 13, 1990
Ridogrel, a combined thromboxane synthase inhibitor and receptor blocker, decreases elevated plasma beta-thromboglobulin levels in patients with documented peripheral arterial disease
B Hoet, J Arnout, C Van Geet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1988
Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro
M Baba, R Pauwels, J Balzarini, et al.
Thrombosis and Haemostasis
|
February 1, 1993
A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate
K Peerlinck, J Arnout, J G Gilles, et al.
Page
of 10